GV 2021 Gp, L.P., 10% Owner at Prime Medicine, Inc. (PRME), sold 169,224 shares at $15.06 ($1.7M) on 2023-06-20, disclosed to the SEC on 2023-06-22.
Scheduled sale ($1.7M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 37,405 | $0 | 0.0% |
| 2 | $15.06 | 37,405 | $563K | 33.2% |
| 3 | $15.06 | 37,405 | $563K | 33.2% |
| 4 | $0.00 | 19,003 | $0 | 0.0% |
| 5 | $14.97 | 19,003 | $284K | 16.8% |
| 6 | $14.97 | 19,003 |
| $284K |
| 16.8% |
| Total | $10.02 avg | 169,224 | $1.7M | 100% |
| Filing → |
| PRME | SELL | 2023-06-07 | $1.8M | — | Filing → |
| PRME | SELL | 2023-05-22 | $2.5M | — | Filing → |
| PRME | SELL | 2023-05-10 | $11.9M | — | Filing → |